Results: 4

1.
Exhibit 1

Exhibit 1. Trends in Average Survival from Cancer Diagnosis in the United States and 10 European Countries. From: An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.

Source: Authors' calculations using data from SEER, EUROCARE-3, and EUROCARE-4 databases.
Note: Results are standardized by age, gender, and cancer site. Includes EU countries for which survival data were consistently available over the analysis period: Finland, France, Germany, Iceland, Norway, Slovakia, Slovenia, Scotland, Sweden, and Wales.
1983-19851986-19881989-19911992-19941995-1999 US8.458999.181659.7051810.233611.0568EU7.102717.58397.939178.373749.25581

Tomas Philipson, et al. Health Aff (Millwood). 2012 April;31(4):10.1377/hlthaff.2011.1298.
2.
Exhibit 2

Exhibit 2. Aggregate Value of US Survival Gains in Excess of European Survival Gains for US Patients Diagnosed in 1983-1999, by Site. From: An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.

Source: Authors' calculations using data from SEER, EUROCARE-3, and EUROCARE-4 databases.
Note: Abbreviations: AML, acute myeloid leukemia; CML chronic myeloid leukemia, NHL, non-Hodgkin lymphoma. Results are standardized by age and gender. Includes EU countries for which survival data were consistently available over the analysis period: Finland, France, Germany, Iceland, Norway, Slovakia, Slovenia, Scotland, Sweden, and Wales.
Cancer TypeBillions of U.S. Dollars (2010) Corpus uteri−66.91817655Colorectal−45.53241235Melanoma−2.501591049Chronic myeloid leukemia15.31767163Acute myeloid leukemia29.66885236Breast173.1234132Prostate626.7031053

Tomas Philipson, et al. Health Aff (Millwood). 2012 April;31(4):10.1377/hlthaff.2011.1298.
3.
Exhibit 4

Exhibit 4. Country-Level Correlations between Cancer Spending and Average Cancer Survival. From: An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.

Source: Authors' calculations based on data from SEER, EUROCARE-3, EUROCARE-4, OECD, and the Karolinska Institute.
Note: Results are standardized by age, gender, and cancer site. Includes EU countries for which survival data were consistently available over the analysis period: Finland, France, Germany, Iceland, Norway, Slovakia, Slovenia, Scotland, Sweden, and Wales. Estimates of the average gain in cancer survival against the change in cancer expenditures were calculated for the period 1995-1999 relative to the period 1983-1985. Data on health expenditures by country from the OECD were geometrically extrapolated for some years when unavailable.

Tomas Philipson, et al. Health Aff (Millwood). 2012 April;31(4):10.1377/hlthaff.2011.1298.
4.
Exhibit 3

Exhibit 3. US Survival Benefits, Costs, and Surplus to Average Cancer Patients in Excess of European Countries. From: An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.

Source: Authors' calculations based on data from SEER, EUROCARE-3, EUROCARE-4, OECD, and the Karolinska Institute.
Note: Results are standardized by age, gender, and cancer site. Estimates are expressed in 2010 US dollars. The value of a life-year was set at $150,000. Survival gains and costs are discounted at 3% per year to 1999. Costs are converted to 2010$ using the Consumer Price Index. Includes EU countries for which survival data were consistently available over the analysis period: Finland, France, Germany, Iceland, Norway, Slovakia, Slovenia, Scotland, Sweden, and Wales. Data on health expenditures by country from the OECD were geometrically extrapolated for some years when unavailable.
1983-19851986-19881989-19911992-19941995-1999 Benefits064923.8189102718.63111766.46111766.46Costs014213.0519188.2817507.4514660.57Surplus050710.773883530.34794259.01168850.608

Tomas Philipson, et al. Health Aff (Millwood). 2012 April;31(4):10.1377/hlthaff.2011.1298.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk